First steps to develop and validate a CFPD model in order to support the design of nose-to-brain delivered biopharmaceuticals
L Engelhardt, M Röhm, C Mavoungou… - Pharmaceutical …, 2016 - Springer
Purpose Aerosol particle deposition in the human nasal cavity is of high interest in particular
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals
L Engelhardt, M Röhm, C Mavoungou… - Pharmaceutical …, 2016 - infona.pl
Purpose Aerosol particle deposition in the human nasal cavity is of high interest in particular
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals
L Engelhardt, M Röhm, C Mavoungou… - Pharmaceutical …, 2016 - search.proquest.com
Purpose Aerosol particle deposition in the human nasal cavity is of high interest in particular
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals
L Engelhardt, M Röhm, C Mavoungou… - Pharmaceutical …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose Aerosol particle deposition in the human nasal cavity is of high interest in particular
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
[引用][C] First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals
L Engelhardt, M Rohm, C Mavoungou… - Pharmaceutical …, 2016 - oparu.uni-ulm.de
First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain
Delivered Biopharmaceuticals Toggle navigation English Deutsch Deutsch English Deutsch …
Delivered Biopharmaceuticals Toggle navigation English Deutsch Deutsch English Deutsch …
First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.
L Engelhardt, M Röhm, C Mavoungou… - Pharmaceutical …, 2016 - search.ebscohost.com
Purpose: Aerosol particle deposition in the human nasal cavity is of high interest in particular
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.
L Engelhardt, M Röhm, C Mavoungou… - Pharmaceutical …, 2016 - europepmc.org
Purpose Aerosol particle deposition in the human nasal cavity is of high interest in particular
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
for intranasal central nervous system (CNS) drug delivery via the olfactory cleft. The …
[引用][C] First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals
L Engelhardt, M Rohm, C Mavoungou, K Schindowski… - 2016 - oparu.uni-ulm.de